REQUEST A DEMO
Total
USD $0.00
Search more companies

Apex Healthcare Bhd (Malaysia)

Main Activities: Pharmaceutical and Medicine Manufacturing | Management of Companies and Enterprises
Full name: Apex Healthcare Bhd Profile Updated: February 06, 2022
Buy our report for this company USD 29.95 Most recent financial data: 2021 Available in: English Download a sample report

Apex Healthcare Berhad is engaged in investment holding and the provision of management services. Apex operates in two segments: manufacturing of pharmaceutical products, and marketing, distribution and retailing of pharmaceutical products. Apex distributes its products under the brand names of XepaSP, AVEX, KAPS and PURE HEALTH, as well as medicated powder under the brand name of AGNESIA. Apex was founded in 1998 and based in Malacca, Malaysia. The company is listed under the Main Market.

Legal Address
1-5 Jalan Ttc 1,Cheng Industrial Estate
Melaka; Malacca; Postal Code: 75250

Contact Details: Purchase the Apex Healthcare Bhd report to view the information.

Website: http://www.apexhealthcare.com.my/

Basic Information
Total Employees:
Purchase the Apex Healthcare Bhd report to view the information.
Outstanding Shares:
Purchase the Apex Healthcare Bhd report to view the information.
Financial Auditors:
Purchase the Apex Healthcare Bhd report to view the information.
Ratings:
Purchase the Apex Healthcare Bhd report to view the information.
Incorporation Date:
1998
Key Executives
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
29.84%
Subsidiaries
ABio Marketing Sdn Bhd
100%
Apex Pharma Marketing Pte Ltd (Singapore)
100%
Apex Pharmacy Corporate Sdn Bhd
100%
Company Performance
Financial values in the chart are available after Apex Healthcare Bhd report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Net sales revenue
10.31%
Total operating revenue
9.63%
Operating profit (EBIT)
6.87%
EBITDA
5.41%
Net Profit (Loss) for the Period
6.11%
Total assets
9.54%
Total equity
8.31%
Operating Profit Margin (ROS)
-0.31%
Net Profit Margin
-0.31%
Return on Equity (ROE)
-0.24%
Debt to Equity Ratio
-1.7%
Quick Ratio
0.18%
Cash Ratio
0.05%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?